CRL4(DCAF2) negatively regulates IL-23 production in dendritic cells and limits the development of psoriasis.
CRL4(DCAF2) negatively regulates IL-23 production in dendritic cells and limits the development of psoriasis.
复制标题
CRL4(DCAF2) 负向调节树突状细胞中 IL-23 的产生并限制银屑病的发展
DOI:
10.1084/jem.20180210
复制
发表时间:
2018-08-06
期刊:
影响因子:
--
通讯作者:
Jin J
中科院分区:
文献类型:
--
作者:
Huang T;Gao Z;Zhang Y;Fan K;Wang F;Li Y;Zhong J;Fan HY;Cao Q;Zhou J;Xiao Y;Hu H;Jin J
Deregulated NF-κB activation is linked to immunological disorders. Huang et al. revealed CRL4DCAF2 as a negative regulator in controlling NIK stability in DCs. Lower level of DCAF2 is associated with noncanonical NF-κB activation and hyperproduction of IL-23 in psoriasis patients. The E3 ligase CRL4DCAF2 is believed to be a pivotal regulator of the cell cycle and is required for mitotic and S phase progression. The NEDD8-targeting drug MLN4924, which inactivates cullin ring-finger ubiquitin ligases (CRLs), has been examined in clinical trials for various types of lymphoma and acute myeloid leukemia. However, the essential role of CRL4DCAF2 in primary myeloid cells remains poorly understood. MLN4924 treatment, which mimics DCAF2 depletion, also promotes the severity of mouse psoriasis models, consistent with the effects of reduced DCAF2 expression in various autoimmune diseases. Using transcriptomic and immunological approaches, we showed that CRL4DCAF2 in dendritic cells (DCs) regulates the proteolytic fate of NIK and negatively regulates IL-23 production. CRL4DCAF2 promoted the polyubiquitination and subsequent degradation of NIK independent of TRAF3 degradation. DCAF2 deficiency facilitated NIK accumulation and RelB nuclear translocation. DCAF2 DC-conditional knockout mice displayed increased sensitivity to autoimmune diseases. This study shows that CRL4DCAF2 is crucial for controlling NIK stability and highlights a unique mechanism that controls inflammatory diseases.
登录
查看更多内容
影响因子:
30.5
作者:
通讯作者:
--
DOI:
10.1007/978-1-4939-2926-9_15
发表时间:
2016-01-01
期刊:
CYCLIN-DEPENDENT KINASE (CDK) INHIBITORS: METHODS AND PROTOCOLS
影响因子:
--
作者:
Hoodless, Laura J.;Robb, Calum T.;Rossi, Adriano G.
通讯作者:
Rossi, Adriano G.
影响因子:
11.4
作者:
Chow, EK;O'Connell, RM;Cheng, GH
通讯作者:
Cheng, GH
影响因子:
50.3
作者:
Kortylewski M;Xin H;Kujawski M;Lee H;Liu Y;Harris T;Drake C;Pardoll D;Yu H
通讯作者:
Yu H
影响因子:
15.3
作者:
Altznauer, F;Martinelli, S;Yousefi, S;Thürig, C;Schmid, I;Conway, EM;Schöni, MH;Vogt, P;Mueller, C;Fey, MF;Zangemeister-Wittke, U;Simon, HU
通讯作者:
Simon, HU